National Center for Tumor Diseases (NCT) Heidelberg
Benjamin Sobol is currently a resident at University Hospital Heidelberg, focusing on targeting antiapoptotic Bcl-2 proteins in solid tumors. Prior to this, Sobol worked as an M.D. candidate at National Center for Tumor Diseases (NCT) Heidelberg. Sobol also has experience as a histology tutor at Institut Für Anatomie Und Zellbiologie and as a lecturer for the university’s examination review course at Ruprecht-Karls-Universität Heidelberg. Additionally, Sobol completed an elective period internship in general surgery at Kilimanjaro Christian Medical Center (KCMC) and a medical clerkship in trauma surgery at Sheba Medical Center. Education-wise, Sobol attended Heidelberg University and Charles University.
National Center for Tumor Diseases (NCT) Heidelberg
The National Center for Tumor Diseases (NCT) Heidelberg is a joint institution of the German Cancer Research Center (DKFZ), Heidelberg University Hospital and German Cancer Aid. The NCT's goal is to link promising approaches from cancer research with patient care from diagnosis to treatment, aftercare and prevention. The interdisciplinary tumor outpatient clinic is the central element of the NCT. Here the patients benefit from an individual treatment plan prepared in a timely manner in interdisciplinary expert rounds, the so-called tumor boards. Participation in clinical studies provides access to innovative therapies. The NCT thereby acts as a pioneering platform that translates novel research results from the laboratory into clinical practice. The NCT cooperates with self-help groups and supports them in their work. Since 2015, a second site for the NCT beside Heidelberg has been under development in Dresden.